Division
of Pediatric Allergy and Immunology, Johns Hopkins University School Medicine, Baltimore, MD. RATIONALE: Recent retrospective research associated early life acid suppressive medication with food allergies. We sought to prospectively evaluate the association between acid suppressive medication in infancy and development of IgE-mediated food allergy in early childhood. METHODS: The Gastrointestinal Microbiome and Allergic Proctocolitis (GMAP) Study is an ongoing prospective observational cohort study of 1003 healthy newborn infants designed to evaluate the development of food allergies in their first 3 years of life. IgE-mediated food allergy was determined by independent agreement of two allergist reviewers based on clinical reactivity and documented IgE sensitivity. RESULTS: 797 infants were analyzed (46% female, 89% term, 31% delivered via caesarian-section, 8% neonatal antibiotics) with a current median age of 36 [19, 54] months. 153 (19%) were exposed to acid suppressive medication, 45 (5%) were exposed to a proton pump inhibitor and 115 (13%) were exposed to a histamine-2 receptor antagonist, in their first six months of life. To date, 51 (6%) of children have developed a confirmed or probable IgE-mediated food allergy, most commonly to egg, peanut, tree nuts, and milk. Use of acid suppressive medication in the first six months of life was not associated with development of IgE-mediated food allergy in early childhood (OR 0.77 [0.31, 1.71 ], p50.59). CONCLUSIONS: Contrary to a recent retrospective report, early exposure to acid suppressive medication is not prospectively associated with development of IgE-mediated food allergy by age 3 in this cohort.
765
Postnatal probiotics and allergic disease in very preterm infants: sub-study to the ProPrems randomized trial The Royal Women's Hospital, Melbourne, Australia, 6 Royal Children's Hospital, Parkville, Australia. RATIONALE: Probiotic supplementation pre and/or post natal has been suggested to prevent allergic disease, in particular eczema; however no studies have investigated probiotics for prevention of allergic diseases in very preterm infants. We therefore aim to evaluate the effect of a postnatal probiotic combination on development of allergic diseases and atopic sensitization, in very preterm infants in early childhood. METHODS: This sub-study was an a priori secondary outcome of the Australasian ProPrems multi-centre, double-blind, placebo-controlled randomized trial. ProPrems randomized 1099 very preterm infants to receive a probiotic combination or placebo from soon after birth until discharge from hospital or term corrected age (CA), whichever was earlier. Victorian infants were eligible for this sub-study. Allergic disease incidence in the first two years of life was assessed by questionnaire, clinical examination and skin prick tests to common allergens. Logistic regression models were used to determine the association between probiotics administration and allergic disease outcomes, adjusting for baseline imbalances. RESULTS: 281 of 453 eligible infants were included. Data were analysed (127 probiotic group, 154 placebo group). The median corrected age (CA) was 16 months CA in both groups at allergy assessment. The incidence of allergic diseases (eczema, atopic eczema, food allergy and wheeze) and atopic sensitization in the first two years of life was similar in the probiotic and placebo groups. CONCLUSIONS: This study found no effect of postnatal administration of a probiotic combination on the incidence of allergic diseases or atopic sensitization in the first two years of life.
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Tick Salivary Extract Induces Alpha-Gal Allergy in Alpha-Gal Deficient Mice Shailesh Choudhary, PhD, Onyinye I. Iweala, MD PhD, Claire T. Addison, and Scott P. Commins, MD PhD; University of North Carolina at Chapel Hill, Chapel Hill, NC. RATIONALE: Development of sIgE to galactose-alpha-1,3-galactose (alpha-gal) and red meat allergy has been associated with tick bites; however, controlled experiments directly linking tick bites with alpha-gal allergy are lacking. In this study, we immunized mice deficient in alpha-gal (AGKO) with tick salivary gland extract (TSGE) to determine whether alpha-gal sIgE response and red meat allergy would develop. METHODS: Ten week old AGKO mice on C57Bl6/J background were given either Amblyomma americanum TSGE intradermally (50 mg) or saline on days 0, 7, 21, 28, 42, 49 . IgE and IgG were assessed on day 56 by ELISA. Mice were challenged orally with 400 mg pork meat on day 64 and core body temperature was measured. RESULTS: Compared to controls, mice treated with TSGE had elevated total IgE and IgG at day 56 (0.6060.12 ng/mL vs 113.2624.77 ng/mL, p<0.0001; 98.07610.32 mg/mL vs 253.4638.93 mg/mL, p<0.0001, respectively). Alpha-gal sIgE was increased in response to TSGE treatment (undetected vs 40.3 pg/mL). Core body temperature decreased following pork challenge with maximal decrease at 30 minutes in the TSGE-treated mice (34.3960.568C) but not in control mice. Interestingly, female mice had higher total IgE responses to TSGE treatment (179.1639.86 vs 56.98617.45 ng/ml) but male mice had larger declines in mean body temperature (-4.9960.6 vs -3.1860.828C) . CONCLUSIONS: AGKO mice treated with TSGE recapitulate the delayed allergy to red meat seen in humans and establish the central role of tick bites. In addition, our model serves as a platform for mechanistically studying this new food allergy -already revealing potentially important sex-related differences.
